JCU (4975) FY2027 Q1 Earnings Report

Quick View

Executive Summary

Revenue, led by the core Chemical Business, maintained its trend of year-on-year increases for the sixth consecutive period; however, operating income declined because the increase in SG&A expenses exceeded revenue growth, resulting in higher revenue but lower operating profit. Revenue was ¥74.9B (+6.5% YoY), operating income was ¥27.4B (△2.3%), ordinary income was ¥29.1B (+2.2%), and net income (net income attributable to owners of the parent, equal to consolidated net income) was ¥20.8B (+2.5%). Although the increase in SG&A expenses pressured profit at the operating level, non-operating income, including foreign exchange gains, provided support, enabling modest increases in ordinary income and net income.

Factors Affecting Results

【Revenue】Revenue increased 6.5% YoY to ¥74.9B. By segment, Chemical led the increase, generating ¥70.6B (+18.2% YoY) and accounting for 94.2% of total company revenue, while Equipment declined significantly to ¥4.3B (△59.2%), restraining the overall increase in revenue.

【Profit and Loss】Operating income declined 2.3% YoY to ¥27.4B. The gross margin improved by +1.1pt from the previous year to 69.0%; however, the SG&A expense ratio rose +4.5pt to 32.5%, causing the operating margin to decline to 36.5% (△3.3pt YoY). The primary causes of the increase in SG&A expenses appear to have been higher fixed costs, including salaries and allowances and depreciation, while underabsorption of fixed costs associated with the sharp decline in Equipment revenue may also have pressured the company-wide margin. Meanwhile, ordinary income increased 2.2% YoY to ¥29.1B and net income increased 2.5% to ¥20.8B, as non-operating income of ¥1.8B, including a foreign exchange gain of ¥1.2B, offset the decline in operating income. Extraordinary income was limited to extraordinary gains of ¥0.02B and was immaterial; therefore, it was not a factor behind the divergence between ordinary income and net income. In summary, operating income declined, but the contribution from non-operating income resulted in higher revenue and net income at the final stage.

Segment Analysis

The Chemical Business recorded revenue of ¥70.6B (+18.2% YoY), operating income of ¥29.4B (+3.4%), and a profit margin of 41.6%, maintaining high profitability and generating the majority of company-wide operating income. The Equipment Business contracted substantially, with revenue of ¥4.3B (△59.2%), operating income of ¥0.6B (△72.1%), and a profit margin of 13.1%, directly contributing to the decline in company-wide operating income. The gap in profit margins between the two segments is substantial, and the earnings structure remains highly dependent on Chemical. Company-wide expenses (adjustments) were △¥2.6B, almost unchanged from △¥2.5B in the previous year, indicating that fluctuations in segment profitability were the primary cause of the decline in operating income.

Key Financial Metrics

【Profitability】The operating margin was 36.5% (△3.3pt from approximately 36.5% in the previous year), while the net profit margin was 27.7%. The increase in the SG&A expense ratio to 32.5% (+4.5pt YoY) exceeded the improvement in the gross margin to 69.0% (+1.1pt), resulting in a contraction in operating-level margins. 【Cash Flow Quality】Trade receivables (notes and accounts receivable) were ¥81.2B and inventories were ¥22.4B, both remaining almost flat from the previous year. Meanwhile, accounts payable declined significantly to ¥10.4B from ¥20.3B in the previous year, suggesting that the reduction in trade payables may have absorbed cash through working capital. 【Investment Efficiency】ROE was 3.7% (quarterly result). Under DuPont analysis, it comprised a net profit margin of 27.7%, total asset turnover of 0.124x, and financial leverage of 1.08x, indicating that profitability is the primary earnings driver. EPS was ¥84.29 (¥81.25 in the previous year, YoY +3.7%). 【Financial Soundness】The equity ratio rose to 92.5% from 87.1% in the previous year, while cash and deposits of ¥222.7B accounted for 36.7% of total assets, indicating that the company maintains an extremely conservative financial structure.

Cash Flow Analysis

As no cash flow statement has been disclosed, cash flow trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥222.7B, down from ¥242.3B in the previous year, and the significant decline in accounts payable to ¥10.4B from ¥20.3B is believed to have been a cash outflow factor through the reduction in trade payables. Meanwhile, construction in progress declined substantially to ¥10.3B from ¥55.9B, while machinery, equipment, and vehicles increased to ¥35.7B from ¥10.1B, suggesting that investment projects were completed and transferred to operating assets. Land also increased to ¥29.9B from ¥21.5B, indicating potential for additional capital investment. Net assets increased to ¥560.9B from ¥545.7B in the previous year, supported by the accumulation of retained earnings as well as increases in foreign currency translation adjustments and valuation difference on available-for-sale securities. Cash on hand remains ample, securing financial capacity for both investment and shareholder returns.

Earnings Quality

The majority of current-period profit was derived from recurring income based on operating activities, while extraordinary gains were only ¥0.02B and had little temporary impact on net income. Foreign exchange gains accounted for ¥1.2B of non-operating income of ¥1.8B. Although this represented only approximately 1.6% of revenue, the gain contributed to the increase in ordinary income by offsetting the decline in operating income. As foreign exchange gains are subject to fluctuations in foreign exchange rates, their recurrence is limited and this should be noted. The difference between ordinary income of ¥29.1B and net income of ¥20.8B was attributable to income taxes of ¥8.3B. The effective tax rate was approximately 28.6%, a standard level, with no unusual factors identified in the tax burden. Comprehensive income was ¥28.5B, ¥7.7B higher than net income of ¥20.8B. The primary causes of the difference were foreign currency translation adjustments of +¥4.5B and valuation difference on available-for-sale securities of +¥3.2B, indicating that valuation-related non-operating items boosted comprehensive income.

Earnings Forecast and Guidance

The Q1 progress rates against the full-year earnings forecasts were 22.4% for revenue (¥74.9B/¥334.0B), 22.3% for operating income (¥27.4B/¥123.0B), 23.3% for ordinary income (¥29.1B/¥125.0B), and 23.6% for net income (¥20.8B/¥88.0B). Compared with the simple benchmark of 25% for equal progress across four quarters, all metrics were slightly below this level, with the deviations in revenue and operating income being relatively large. The sharp decline in Equipment revenue and the front-loaded increase in SG&A expenses appear to have been factors. Achievement of the full-year plan is therefore expected to depend on a recovery in the business during the second half and expense control. There were no revisions to the earnings or dividend forecasts during the quarter.

Shareholder Returns

The full-year dividend forecast is ¥180 per share, implying a payout ratio of approximately 50.4% against full-year forecast EPS of ¥357.44. Compared with the previous year's actual dividend of ¥41 (the actual amount combining interim and year-end dividends, etc.), the company is moving toward a dividend increase. Against forecast full-year net income of ¥88.0B, the total dividend amount (estimated based on approximately 24.62 million effective shares outstanding) is at a level sufficiently covered by earnings. Given the substantial cash and deposits of ¥222.7B and the strong financial position reflected by an equity ratio of 92.5%, there is currently no need for monitoring from the perspective of securing funds for dividends.

Risk Factors

1. Segment concentration risk: Chemical accounts for 94.2% of revenue (¥70.6B/¥74.9B), and the business portfolio is highly dependent on demand trends in Chemical.

2. Slowdown in the Equipment Business: Revenue declined to ¥4.3B (△59.2% YoY) and operating income to ¥0.6B (△72.1%), making it the primary cause of the decline in the company-wide operating margin through underabsorption of fixed costs.

3. Continued cost increases: The SG&A expense ratio rose to 32.5% (+4.5pt YoY). If expense growth exceeding revenue growth (+6.5%) continues, it could place further pressure on the operating margin.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the operating margin and net profit margin are substantially above the industry median, indicating a high level of profitability within the industry.

Growth and Capital Efficiency

The revenue growth rate is approximately in line with the industry median, indicating an industry-average pace of growth.

※Source: Compiled by the company

Key Takeaways from the Results

1. The profit margin of the core Chemical Business remained high at 41.6% and continues to serve as the center of company-wide profitability. Meanwhile, the sharp slowdown in Equipment was the primary cause of the decline in operating income. The widening performance gap between the segments is an important point for monitoring the earnings structure.

2. The SG&A expense ratio rose +4.5pt YoY, and the increase in expenses exceeding the improvement in the gross margin pressured the operating margin. Future trends in expense control are expected to determine the direction of margin trends.

3. The strong financial position, reflected in an equity ratio of 92.5% and cash and deposits of ¥222.7B, indicates resilience to changes in the business environment. Financial capacity remains secured even though full-year progress is slightly below plan.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type model with an explicit 5-year fade). It is not a forecast of the market share price or a recommendation to take any specific investment action.

Sensitivity: ¥2,670–¥2,823 at ±1% for the cost of equity, and ¥2,734–¥2,761 at ±0.1 for ω.

Notes:

• Net assets as of the end of the quarter are used (there is a timing difference relative to the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual income model / Interest rate reference month: 2026-07 / This value does not predict or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional adviser as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

JCU delivered a strong top-line and net-profit Q1 FY2027 result, but operating-profit conversion weakened as segment mix shifted sharply toward the higher-margin chemicals business while its own margin moderated. Revenue rose 6.5% YoY to ¥7.49bn. Gross profit increased 8.3% YoY to ¥5.17bn, exceeding sales growth. The gross margin expanded by 116bp YoY to 69.0%, indicating favorable product mix and/or cost absorption at the gross-profit level. Operating income, however, declined 2.3% YoY to ¥2.74bn. The operating margin compressed 329bp YoY to 36.5% from 39.8%. SG&A expenses increased 23.4% YoY to ¥2.43bn, substantially faster than revenue growth. This SG&A increase was the principal reason gross-profit growth did not translate into operating-income growth. Ordinary income nevertheless rose 2.2% YoY to ¥2.91bn, aided by ¥123m of foreign-exchange gains within non-operating income. Net income rose 2.5% YoY to ¥2.08bn, and the net margin was 27.7%, down 106bp YoY. Net income was therefore supported partly by non-operating gains rather than by operating-profit expansion. The Chemicals Business remained the core business, accounting for 94.2% of revenue and 98.1% of aggregate segment profit before corporate costs. The Equipment Business saw a severe contraction in both sales and profit, making consolidated earnings more dependent on the chemicals franchise. The balance sheet remains exceptionally conservative, with ¥22.27bn of cash and deposits, a 937.9% current ratio, and D/E of 0.08x. Working-capital intensity is nevertheless a material operational focus, with quality alerts for high receivable days, high inventory days, and a long cash-conversion cycle. Full-year guidance implies Q1 progress broadly in line with a normal 25% seasonal benchmark, although the planned full-year operating-income growth of only 1.2% indicates limited margin recovery embedded in the forecast. The full-year DPS forecast of ¥180 implies a dividends-only payout ratio of 50.4%, which appears proportionate to forecast EPS of ¥357.44.

Profitability Analysis

Annualized DuPont ROE is 14.8%, comprising a 27.7% net profit margin, 0.494x asset turnover, and 1.08x financial leverage. Returns are driven overwhelmingly by an unusually high earnings margin rather than leverage, consistent with the company’s net-cash-rich and equity-funded capital structure. The 27.7% net margin remains excellent, but it declined from an implied 28.8% in the prior-year quarter as operating-margin pressure outweighed the benefit of non-operating income. The largest adverse operating change was the 329bp decline in operating margin to 36.5%. Gross margin improved 116bp to 69.0%, so the operating-margin decline originated below gross profit. SG&A rose 23.4% YoY to ¥2.43bn against 6.5% sales growth, reducing operating leverage. Salaries and allowances rose 9.7% YoY to ¥690m and bonuses rose 3.2% YoY to ¥193m; the broader SG&A increase was concentrated in other SG&A expenses, which rose 19.9% to ¥1.13bn. Chemicals Business revenue increased 18.2% YoY to ¥7.06bn and segment profit increased 3.4% to ¥2.94bn, but its segment margin fell 596bp to 41.6%. Equipment Business revenue fell 59.2% YoY to ¥435m and segment profit fell 72.1% to ¥57m, with margin down 605bp to 13.1%. Corporate costs increased 5.7% YoY to ¥259m, further diluting consolidated operating income. Ordinary income exceeded operating income by ¥170m, primarily reflecting foreign-exchange gains of ¥123m, interest income of ¥24m, and dividend income of ¥23m. The tax burden was normal at 0.713, equivalent to a 28.6% effective tax rate, while the interest burden of 1.063 confirms that net financial income modestly augmented pre-tax earnings. Interest coverage was an exceptionally strong 2,737x. JGAAP goodwill amortization is not a material earnings consideration on the reported balance sheet, where intangible assets are only 0.6% of total assets.

Growth Assessment

Revenue growth was led by the Chemicals Business, whose ¥7.06bn of Q1 revenue more than offset the ¥630m YoY decline in Equipment Business sales. The Chemicals Business contributed essentially all of the consolidated top-line expansion and remains the principal source of earnings resilience. Its 18.2% sales growth demonstrates continued demand momentum, but the decline in segment margin to 41.6% shows that revenue growth is currently carrying a lower incremental profit conversion than a year earlier. The Equipment Business’s 59.2% revenue decline increases quarter-to-quarter volatility and makes recovery in equipment demand an important swing factor for the full-year outcome. Consolidated gross-margin expansion to 69.0% is constructive, yet the 23.4% SG&A increase means revenue growth alone will not guarantee operating-profit growth. Full-year guidance calls for revenue of ¥33.40bn, up 12.6% YoY, operating income of ¥12.30bn, up 1.2%, ordinary income of ¥12.50bn, up 0.4%, and net income of ¥8.80bn. Q1 progress is 22.4% for sales, 22.3% for operating income, 23.3% for ordinary income, and 23.6% for net income. These progress rates are within 2.7 percentage points of the standard 25% Q1 benchmark and do not indicate a material deviation from the annual plan. The guidance profile nevertheless implies that the company expects full-year revenue growth to materially outpace operating-profit growth, consistent with continuing margin and/or expense pressure. Foreign-exchange gains were ¥123m in Q1, equal to 4.5% of operating income, so repeatability of ordinary-income growth is partly sensitive to currency movements. The ¥2m gain on sale of non-current assets was immaterial relative to net income and does not alter the underlying earnings view.

Financial Health

Financial health is very strong. Current assets of ¥36.83bn exceeded current liabilities of ¥3.93bn by ¥32.90bn, producing working capital of ¥32.90bn and a current ratio of 937.9%. The quick ratio was also exceptionally high at 881.0%, supported mainly by ¥22.27bn of cash and deposits. Cash represented 36.7% of total assets and exceeded total liabilities of ¥4.52bn by ¥17.75bn. Total liabilities represented only 7.5% of total assets, while total equity was ¥56.09bn and the capital adequacy ratio was 92.5%. D/E of 0.08x is conservative and materially below the 2.0x risk threshold. Current portions of long-term loans and lease obligations totaled only ¥30m, indicating no meaningful debt-driven maturity mismatch relative to liquid current assets. Accounts payable declined ¥991m YoY, or 48.9%, to ¥1.04bn. This reduction contributed to the sharp decrease in current liabilities and further strengthened headline liquidity, but it also reduces supplier-financing support for the operating cash cycle. Property, plant and equipment was ¥19.81bn, or 32.7% of total assets, reflecting a meaningful manufacturing asset base. Construction in progress was ¥1.03bn, or 5.2% of PPE, indicating an active but not unusually large investment pipeline. Asset retirement obligations were ¥69m, equal to 1.5% of total liabilities, below the 2% benchmark for material environmental-obligation concern.

Notable B/S Changes

Accounts payable: -¥9.91bn (-48.9%) to ¥1.04bn — materially reduced supplier financing contributed to stronger current liquidity but may lengthen the net operating cash cycle. Construction in progress: -¥4.57bn (-81.6%) to ¥1.03bn — suggests substantial commissioning or completion of the prior investment pipeline; execution and utilization of the associated manufacturing assets should be monitored. Machinery: +¥2.56bn (+252.5%) to ¥3.57bn — indicates a major increase in installed production equipment, consistent with investment completion and raising the importance of capacity utilization and return generation. Land: +¥835m (+38.8%) to ¥2.99bn — a significant fixed-asset increase that adds to the manufacturing asset base. Provision for bonuses: -¥194m (-45.0%) to ¥237m — reduced current obligations supported the decline in current liabilities. Income taxes payable: -¥1.08bn (-57.0%) to ¥814m — materially reduced current liabilities and improved headline liquidity.

Cash Flow Quality

High reported profitability is not accompanied by cash-flow figures in the supplied period data, so cash conversion and free-cash-flow coverage cannot be quantified. Operating working-capital quality requires close attention. The HIGH_RECEIVABLE_DAYS alert identifies DSO of 99 days, above the 60-day warning threshold. The root cause is a comparatively large receivables base relative to quarterly sales, including trade receivables of ¥8.12bn, notes receivable of ¥652m, and electronically recorded monetary claims of ¥491m. For a specialty chemicals and equipment manufacturer, extended customer collection periods can arise from customer credit terms and equipment-project billing, but 99 days remains operationally demanding. The impact is that accounting earnings may convert into cash more slowly and the company must retain greater liquidity to finance sales growth. The HIGH_INVENTORY_DAYS alert of 132 days is above the 90-day warning threshold. A second HIGH_INVENTORY_DAYS alert shows 88 days against a 60-day benchmark; both measures indicate inventory carrying periods that warrant management attention despite differing inventory definitions. The root cause is substantial finished goods of ¥2.24bn, alongside raw materials of ¥942m and work in process of ¥173m. Finished goods are the dominant disclosed inventory category, which elevates the risk of demand forecasting error, product obsolescence, or slower customer drawdown if sales conditions weaken. The LONG_CCC alert of 190 days, above the 120-day threshold, combines slow collections and elevated inventory holding into a lengthy cash cycle. The impact of the long CCC is a greater risk that growth absorbs cash before it contributes to distributable free cash flow. The 48.9% YoY reduction in accounts payable may further weaken the cash-cycle offset from supplier credit. The company’s ¥22.27bn cash balance provides substantial near-term protection, but the receivables, inventory, and CCC alerts remain key indicators of earnings-to-cash conversion risk.

Dividend Sustainability

The full-year dividend forecast is ¥180 per share, compared with forecast EPS of ¥357.44. The implied dividends-only payout ratio is 50.4%, below the 60% sustainability benchmark. Q1 EPS was ¥84.29, representing 23.6% of full-year forecast EPS, broadly consistent with the 25% seasonal benchmark. The large equity base of ¥56.09bn, retained earnings of ¥50.84bn, and cash and deposits of ¥22.27bn provide substantial balance-sheet capacity for the indicated dividend. Low leverage, reflected in D/E of 0.08x, also limits financing pressure on shareholder distributions. Dividend sustainability should nevertheless be assessed alongside management of the extended receivable and inventory cycle, because working-capital absorption can affect cash available for distributions. The disclosed forecast does not indicate a dividend revision.

Risk Assessment

Business risks include High priority — Chemicals Business margin risk: the core Chemicals Business grew revenue 18.2% YoY, but its segment margin fell 596bp to 41.6%; further pricing, mix, raw-material, energy, or manufacturing-cost pressure would have a large consolidated impact., High priority — Equipment Business demand volatility: revenue declined 59.2% YoY to ¥435m and segment profit fell 72.1% YoY, highlighting sensitivity to project timing, customer capital-expenditure cycles, order timing, and acceptance schedules., High priority — Working-capital and demand-planning risk: quality alerts identify 99-day receivables, inventory days of 132 days and 88 days under different measures, and a 190-day CCC; slower collection or inventory turnover could constrain cash conversion., Medium priority — Foreign-exchange risk: Q1 foreign-exchange gains were ¥123m, equal to 4.5% of operating income; a reversal would pressure ordinary income even if operating performance is unchanged., Medium priority — Chemical manufacturing risk: raw-material and energy-price volatility, environmental regulation, product quality requirements, and customer qualification cycles can affect margins, inventory levels, and production continuity..

Financial risks include Low priority — Supplier-credit reduction: accounts payable declined 48.9% YoY to ¥1.04bn, reducing the extent to which payables fund the operating cycle., Low priority — Capital-investment execution: PPE is ¥19.81bn and construction in progress is ¥1.03bn; investment execution and commissioning discipline remain relevant to returns on the manufacturing asset base., Low priority — Environmental obligation exposure: asset retirement obligations are ¥69m, or 1.5% of total liabilities, currently within a manageable range..

Key concerns include The principal earnings concern is the divergence between gross-profit improvement and operating-income decline, caused by SG&A growth of 23.4% versus revenue growth of 6.5%., Ordinary-income growth of 2.2% exceeded operating-income performance partly because of ¥123m in FX gains, reducing the purity of the modest earnings increase., Receivable days, inventory days, and the cash-conversion cycle are the most important operating metrics to monitor for evidence that reported earnings translate into cash., The Chemicals Business is highly dominant, accounting for 98.1% of aggregate segment profit before corporate costs, increasing concentration in its margin trajectory..

Investment Implications

Key takeaways include Revenue growth remained healthy at 6.5% YoY, led by an 18.2% increase in Chemicals Business sales., Operating income fell 2.3% YoY despite a 116bp gross-margin expansion, because SG&A increased 23.4% YoY and Chemicals Business segment margin contracted 596bp., Annualized ROE of 14.8% is good and is achieved with minimal financial leverage of 1.08x, underscoring the strength of the underlying balance sheet., The balance sheet offers substantial resilience: cash was ¥22.27bn, the current ratio was 937.9%, and D/E was 0.08x., The FY2027 plan appears seasonally achievable after Q1, but its modest 1.2% operating-income growth target signals that margin recovery is not assumed., The ¥180 full-year dividend forecast corresponds to a 50.4% dividends-only payout ratio based on forecast EPS..

Metrics to watch include Chemicals Business segment margin and its ability to recover from 41.6%, Equipment Business sales and segment-profit recovery, SG&A growth relative to revenue growth, Operating margin versus the Q1 level of 36.5%, Receivable days of 99 days, inventory-day alerts of 132 days and 88 days, and CCC of 190 days, Foreign-exchange gains or losses and their contribution to ordinary income, Progress toward full-year sales of ¥33.40bn and operating income of ¥12.30bn.

Regarding relative positioning, JCU combines exceptionally high margins and a very conservative capital structure with concentrated reliance on its Chemicals Business. Its annualized 14.8% ROE is close to the excellent 15% threshold without dependence on debt, while its 36.5% operating margin remains far above the 15% excellent benchmark. Relative positioning is tempered by recent margin compression, sharply weaker equipment activity, and working-capital metrics that are less efficient than manufacturing benchmarks.